We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Dana-Farber’s Belfer Institute for Applied Cancer Science to Present and Lead Sessions at the American Association for Cancer Research Annual Meeting 2012
News

Dana-Farber’s Belfer Institute for Applied Cancer Science to Present and Lead Sessions at the American Association for Cancer Research Annual Meeting 2012

Dana-Farber’s Belfer Institute for Applied Cancer Science to Present and Lead Sessions at the American Association for Cancer Research Annual Meeting 2012
News

Dana-Farber’s Belfer Institute for Applied Cancer Science to Present and Lead Sessions at the American Association for Cancer Research Annual Meeting 2012

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Dana-Farber’s Belfer Institute for Applied Cancer Science to Present and Lead Sessions at the American Association for Cancer Research Annual Meeting 2012"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute today announced that the Institute will present data, participate in panel discussions and lead educational sessions at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2012, being held at McCormick Place in Chicago from Saturday, March 31 to Wednesday, April 4. The Belfer Institute of Applied Cancer Science is a fully integrated, collaborative cancer research center offering innovative drug discovery capabilities that range from the identification of cancer-causing genetic mutations to the full validation and selection of new drug targets. Working collaboratively together, across scientific disciplines, and closely with corporate partners, this team of distinguished faculty is driving the discovery of new cancer targets, defining the biological context of those targets and working to co-develop the next generation of novel cancer therapies.

“The Belfer Institute is honored to be presenting and speaking with top oncology researchers at the annual AACR meeting,” said Pasi Janne, M.D., Ph.D., scientific director of the Belfer Institute for Applied Cancer Science. “There has been significant recent progress made in the growth and evolution of the Institute, as evidenced by the recent appointment of Jessie English, our new head of research, and in advancing our collaborations with our strategic partners Merck and Sanofi-Aventis. The Belfer Institute is built upon a tradition of research excellence and we look forward to translating this research into a revolutionary next generation of cancer therapies.”

The Belfer Institute for Applied Cancer Science schedule at AACR is as follows:

-- On Saturday, March 31 at 8 a.m., Dr. Janne will chair the educational session, “Established and Emerging Targets in Lung Cancer.” The session will be held 8-10 a.m. in Room S105 at McCormick Place South.

-- On Monday, April 2 at 8:30 a.m., Jessie M. English, Ph.D., head of research of the Belfer Institute for Applied Cancer Science, will co-chair the professional advancement session, “WICR Career Mentoring Session.” The session will be held 8:30-10:30 a.m. in Continental Ballroom B-C at Hilton Chicago Hotel.

-- On Monday, April 2 at 4:55 p.m., Dr. Janne will be a discussant on the special symposium, “Clinical Trials Symposium 3: Clinical Trials of Novel Agents,” following the abstract presentations. The special symposium will be held 3-5:10 p.m. in Room W183 B/C at McCormick Place West.

-- On Tuesday, April 3 at 1:50 p.m., Dr. Janne will give a presentation titled “Therapeutic strategies with mutant selective EGFR kinase inhibitors.” The presentation will be held as part of the session, “Targeting the EGFR Family with Small Molecules,” being held 1-3 p.m. in Room W181 at McCormick Place West.

Advertisement